EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression

被引:90
作者
Dong, ZZ
Zhang, JT [1 ]
机构
[1] Indiana Univ, Ctr Canc, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Walther Canc Inst, Walther Oncol Ctr, Indianapolis, IN 46202 USA
关键词
D O I
10.1091/mbc.E02-12-0784
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
L-Mimosine, a plant amino acid, can reversibly block mammalian cells at late G1 phase and has been suggested to affect translation of mRNAs such as p27, the CDK inhibitor. However, the mechanism of this effect is not known. Regulation of translation generally occurs at the initiation step that, in mammalian cells, is a complex process that requires multiple eukaryotic initiation factors (eIFs) and ribosome. The effects of mimosine on initiation factors or regulators consequently will influence translation initiation. P170, a putative subunit of eIF3, has been suggested to be nonessential for eIF3 function to form preinitiation complexes and it may function as a regulator for translation of a subset of mRNAs. In this article, we tested this hypothesis and investigated whether eIF3 p170 mediates mimosine effect on mRNA translation. We found that p170 translation was dramatically reduced by mimosine due to its iron-chelating function. The decreased expression of p170 by mimosine caused diminished de novo synthesis of tyrosinated alpha-tubulin and elevated translation of p27 before cell cycle arrest. These observations suggest that p170 is likely an early response gene to mimosine treatment and a mediator for mimosine effect on mRNA translation. The effect of p170 on the synthesis of tyrosinated alpha-tubulin and p27 in a reciprocal manner also suggests that p170 functions as a regulator for mRNA translation.
引用
收藏
页码:3942 / 3951
页数:10
相关论文
共 59 条
[1]  
Agrawal D, 1996, MOL CELL BIOL, V16, P4327
[2]   Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors - A hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1) [J].
Andrus, L ;
Szabo, P ;
Grady, RW ;
Hanauske, AR ;
Huima-Byron, T ;
Slowinska, B ;
Zagulska, S ;
Hanauske-Abel, HM .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) :1807-1818
[3]  
Bachmann F, 1997, CANCER RES, V57, P988
[4]   PURIFICATION AND CHARACTERIZATION OF INITIATION-FACTOR IF-E3 FROM RABBIT RETICULOCYTES [J].
BENNE, R ;
HERSHEY, JWB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3005-3009
[5]   Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3 [J].
Block, KL ;
Vornlocher, HP ;
Hershey, JWB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :31901-31908
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Functional analysis of the interaction between HCV 5′UTR and putative subunits of eukaryotic translation initiation factor elF3 [J].
Buratti, E ;
Tisminetzky, S ;
Zotti, M ;
Baralle, FE .
NUCLEIC ACIDS RESEARCH, 1998, 26 (13) :3179-3187
[8]   Biochemical characterization of mammalian translation initiation factor 3 (eIF3) -: Molecular cloning reveals that p110 subunit is the mammalian homologue of Saccharomyces cerevisiae protein Prt1 [J].
Chaudhuri, J ;
Chakrabarti, A ;
Maitra, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30975-30983
[9]  
Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO
[10]  
2-N